Literature DB >> 25398727

Interventions to Reduce Spasticity and Improve Function in People With Chronic Incomplete Spinal Cord Injury: Distinctions Revealed by Different Analytical Methods.

Lynsey D Duffell1, Geoffrey L Brown2, Mehdi M Mirbagheri3.   

Abstract

BACKGROUND: Spinal cord injury (SCI) results in impaired function, and ankle joint spasticity is a common secondary complication. Different interventions have been trialed with variable results.
OBJECTIVE: We investigated the effects of pharmacological and physical (locomotor training) interventions on function in people living with incomplete motor function loss caused by SCI and used different analytical techniques to understand whether functional levels affect recovery with different interventions.
METHODS: Participants with an incomplete SCI were assigned to 3 groups: no intervention, Lokomat, or tizanidine. Outcome measures were the 10-m walk test, 6-minute walk test, and the Timed Up and Go. Participants were classified in 2 ways: (1) based on achieving an improvement above the minimally important difference (MID) and (2) using growth mixture modeling (GMM). Functional levels of participants who achieved the MID were compared and random coefficient regression (RCR) was used to assess recovery in GMM classes.
RESULTS: Overall, walking speed and endurance improved, with no difference between interventions. Only a small number of participants achieved the MID. Both MID and GMM-RCR analyses revealed that tizanidine improved endurance in high-functioning participants. GMM-RCR classification also showed that speed and mobility improved after locomotor training.
CONCLUSIONS: Improvements in function were achieved in a limited number of people with SCI. Using the MID and GMM techniques, differences in responses to interventions between high-and low-functioning participants could be identified. These techniques may, therefore, have potential to be used for characterizing therapeutic effects resulting from different interventions.
© The Author(s) 2014.

Entities:  

Keywords:  gait; spasticity; spinal cord injury

Mesh:

Substances:

Year:  2014        PMID: 25398727      PMCID: PMC4431959          DOI: 10.1177/1545968314558601

Source DB:  PubMed          Journal:  Neurorehabil Neural Repair        ISSN: 1545-9683            Impact factor:   3.919


  42 in total

1.  Increases in corticospinal tract function by treadmill training after incomplete spinal cord injury.

Authors:  Sarah L Thomas; Monica A Gorassini
Journal:  J Neurophysiol       Date:  2005-07-06       Impact factor: 2.714

Review 2.  A systematic review of functional ambulation outcome measures in spinal cord injury.

Authors:  T Lam; V K Noonan; J J Eng
Journal:  Spinal Cord       Date:  2007-10-09       Impact factor: 2.772

3.  Comparison of training methods to improve walking in persons with chronic spinal cord injury: a randomized clinical trial.

Authors:  Natalia Alexeeva; Carol Sames; Patrick L Jacobs; Lori Hobday; Marcello M Distasio; Sarah A Mitchell; Blair Calancie
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

4.  Growth Mixture Modeling: A Method for Identifying Differences in Longitudinal Change Among Unobserved Groups.

Authors:  Nilam Ram; Kevin J Grimm
Journal:  Int J Behav Dev       Date:  2009

5.  A database of self-reported secondary medical problems among VA spinal cord injury patients: its role in clinical care and management.

Authors:  James S Walter; Jerome Sacks; Raslan Othman; Alexander Z Rankin; Bernard Nemchausky; Rani Chintam; John S Wheeler
Journal:  J Rehabil Res Dev       Date:  2002 Jan-Feb

6.  Laufband locomotion with body weight support improved walking in persons with severe spinal cord injuries.

Authors:  A Wernig; S Müller
Journal:  Paraplegia       Date:  1992-04

7.  Prediction of natural history of neuromuscular properties after stroke using Fugl-Meyer scores at 1 month.

Authors:  Mehdi M Mirbagheri; Thanan Lilaonitkul; William Zev Rymer
Journal:  Neurorehabil Neural Repair       Date:  2011-02-08       Impact factor: 3.919

8.  Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.

Authors:  P W Nance; J Bugaresti; K Shellenberger; W Sheremata; A Martinez-Arizala
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

9.  Recovery of locomotion after chronic spinalization in the adult cat.

Authors:  H Barbeau; S Rossignol
Journal:  Brain Res       Date:  1987-05-26       Impact factor: 3.252

10.  Laufband therapy based on 'rules of spinal locomotion' is effective in spinal cord injured persons.

Authors:  A Wernig; S Müller; A Nanassy; E Cagol
Journal:  Eur J Neurosci       Date:  1995-04-01       Impact factor: 3.386

View more
  5 in total

1.  Dose-Response Outcomes Associated with Different Forms of Locomotor Training in Persons with Chronic Motor-Incomplete Spinal Cord Injury.

Authors:  Evan B Sandler; Kathryn E Roach; Edelle C Field-Fote
Journal:  J Neurotrauma       Date:  2017-01-04       Impact factor: 5.269

2.  Facilitatory effects of anti-spastic medication on robotic locomotor training in people with chronic incomplete spinal cord injury.

Authors:  Lynsey D Duffell; Geoffrey L Brown; Mehdi M Mirbagheri
Journal:  J Neuroeng Rehabil       Date:  2015-03-20       Impact factor: 4.262

3.  The Effectiveness and Safety of Exoskeletons as Assistive and Rehabilitation Devices in the Treatment of Neurologic Gait Disorders in Patients with Spinal Cord Injury: A Systematic Review.

Authors:  Christian Fisahn; Mirko Aach; Oliver Jansen; Marc Moisi; Angeli Mayadev; Krystle T Pagarigan; Joseph R Dettori; Thomas A Schildhauer
Journal:  Global Spine J       Date:  2016-11-03

Review 4.  Robot-assisted gait training (Lokomat) improves walking function and activity in people with spinal cord injury: a systematic review.

Authors:  Ki Yeun Nam; Hyun Jung Kim; Bum Sun Kwon; Jin-Woo Park; Ho Jun Lee; Aeri Yoo
Journal:  J Neuroeng Rehabil       Date:  2017-03-23       Impact factor: 4.262

5.  Reduction in post-spinal cord injury spasticity by combination of peripheral nerve grafting and acidic fibroblast growth factor infusion in monkeys.

Authors:  Wei-Ming Sun; Chao-Lin Ma; Jiang Xu; Ji-Ping He
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.